Kimia Pharmaceutical

Kimia Pharmaceutical Co. is a private Iranian pharmaceutical company headquartered in Isfahan, specializing in the manufacture of generic Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Since its inception in 1993, the company has become a prominent supplier of essential medications, particularly in the fields of endocrinology, neurology, and cardiology. It is recognized as a major producer of Metformin and Gabapentin within the Middle Eastern market, operating facilities that adhere to international Good Manufacturing Practice (GMP) standards. The company's business model focuses on vertical integration, producing both the raw chemical components and the final consumer-ready medications to ensure supply chain stability and affordability.